Fred Restaino, based in United States, is currently a Sr. Director Clinical Supply Chain at POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company. Fred Restaino brings experience from previous roles at POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company, Taysha Gene Therapies, Clinical Supply Management, Inc. and Gilead Sciences. Fred Restaino holds a Philadelphia College of Pharmacy & Science. With a robust skill set that includes IND, Sop, FDA, Pharmacology, Pharmacovigilance and more. Fred Restaino has 3 emails and 2 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.